🇺🇸 FDA
Pipeline program

Liposomal Annamycin (L-Annamycin)

MB-107

Phase 2 small_molecule completed

Quick answer

Liposomal Annamycin (L-Annamycin) for Sarcoma,Soft Tissue is a Phase 2 program (small_molecule) at Moleculin Biotech with 1 ClinicalTrials.gov record(s).

Program details

Company
Moleculin Biotech
Indication
Sarcoma,Soft Tissue
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials